Echosens, Novo Nordisk partner on liver disease campaign

By staff writers

June 27, 2022 -- Echosens and Novo Nordisk are partnering on research support for early diagnosis of nonalcoholic steatohepatitis, as well as increased awareness of the disease.

The companies will work together to support the development of additional clinical validation, to generate real-world evidence, and to support the adoption of noninvasive diagnostic tests for the disease. They will also collaborate on communicating the importance of early diagnosis and management.

Echosens and Novo Nordisk said they have a shared goal of doubling diagnostic rates for people living with advanced to severe steatohepatitis by 2025.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking